LighthouseBlood-based Biomarkers in Alzheimer’s DiseaseBlood-based biomarkers (BBMs) hold promise for a fast, convenient, and simple means to accurately diagnose Alzheimer's Disease.
LighthouseThe New European Clinical Trials Information SystemThe European Medicines Agency (EMA) began mandatory use of the new Clinical Trials Information System (CTIS) as of Tuesday, Jan. 31, 2023.
LighthouseCancer Care Before NGS Is Like Buying Glasses Before an ExamStarting treatment immediately after a cancer diagnosis seems logical; however, doing so before having biomarker testing may be inadvisable.